20/20 OptimEyes Technologies

20/20 OptimEyes Technologies offers a new ocular drug delivery method: a proprietary eye drop formulation that adheres to mucosal surfaces. The proprietary micelle-based drops deliver more drug than conventional eye drops and, due to their adhesive properties, allow for fewer doses and fewer side effects.